Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation

Autores
Bouzat, Cecilia Beatriz
Año de publicación
2018
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapy
Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
XLVII Reunión Anual de la Sociedad Argentina de Biofísica
La Plata
Argentina
Sociedad Argentina de Biofísica
Materia
NICOTINIC RECEPTORS
THERAPEUTIC DRUG TARGETS
DRUG MODULATION
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/201047

id CONICETDig_f98d34f985341267f2bcfd8a9c57dad7
oai_identifier_str oai:ri.conicet.gov.ar:11336/201047
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulationBouzat, Cecilia BeatrizNICOTINIC RECEPTORSTHERAPEUTIC DRUG TARGETSDRUG MODULATIONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapyFil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaXLVII Reunión Anual de la Sociedad Argentina de BiofísicaLa PlataArgentinaSociedad Argentina de BiofísicaSociedad Argentina de BiofísicaCelej, Maria SoledadAcierno, Juan Pablo2018info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectConferenciaBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/201047Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation; XLVII Reunión Anual de la Sociedad Argentina de Biofísica; La Plata; Argentina; 2018; 26-26978-987-27591-6-2CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://biofisica.org.ar/reuniones-cientificas/reunionsab-previas/Nacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:05:20Zoai:ri.conicet.gov.ar:11336/201047instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:05:20.834CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
title Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
spellingShingle Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
Bouzat, Cecilia Beatriz
NICOTINIC RECEPTORS
THERAPEUTIC DRUG TARGETS
DRUG MODULATION
title_short Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
title_full Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
title_fullStr Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
title_full_unstemmed Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
title_sort Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation
dc.creator.none.fl_str_mv Bouzat, Cecilia Beatriz
author Bouzat, Cecilia Beatriz
author_facet Bouzat, Cecilia Beatriz
author_role author
dc.contributor.none.fl_str_mv Celej, Maria Soledad
Acierno, Juan Pablo
dc.subject.none.fl_str_mv NICOTINIC RECEPTORS
THERAPEUTIC DRUG TARGETS
DRUG MODULATION
topic NICOTINIC RECEPTORS
THERAPEUTIC DRUG TARGETS
DRUG MODULATION
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapy
Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
XLVII Reunión Anual de la Sociedad Argentina de Biofísica
La Plata
Argentina
Sociedad Argentina de Biofísica
description Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels widely expressed in neuronal and non-neuronal cells in both vertebrates and invertebrates. In humans, dysfunction of nAChRs is associated with neurological, muscular and immune disorders. The nAChR operates as a molecular machine that transduces the binding of ACh into an electrical signal. Its molecular design has been tuned to function as a near perfect on-off switch that responds to ACh with the efficiency and speed required for proper cell function. We have combined mutagenesis, patch-clamp recordings, single-channel kinetic analysis and in silico studies to unravel the molecular mechanisms and structures underlying nAChR activation and modulation as well as to identify compounds with potential therapeutic use. For the muscle nAChR, a key protagonist in muscle contraction, we have postulated mechanisms that describe its activation and modulation, deciphered how mutations lead to congenital myasthenic syndromes, and explored worm receptors as antiparasitic drug targets. We have also focused on α7 nAChR, which is the homomeric member of the family and is involved in cognition, attention, memory and inflammation. We have revealed unique aspects of α7 activation as well as mechanisms and sites of action of positive allosteric modulators, which are promising therapeutic tools for schizophrenia and Alzheimer’s disease. We have also identified the molecular function of novel heteromeric nAChRs containing the α7 subunit. Overall, our studies have allowed an integrated description of the nAChR, providing information of its molecular function in health and disease states and guiding rational therapy
publishDate 2018
dc.date.none.fl_str_mv 2018
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Conferencia
Book
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/201047
Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation; XLVII Reunión Anual de la Sociedad Argentina de Biofísica; La Plata; Argentina; 2018; 26-26
978-987-27591-6-2
CONICET Digital
CONICET
url http://hdl.handle.net/11336/201047
identifier_str_mv Nicotinic receptors as therapeutic drug targets: Molecular bases of function, dysfunction and drug modulation; XLVII Reunión Anual de la Sociedad Argentina de Biofísica; La Plata; Argentina; 2018; 26-26
978-987-27591-6-2
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://biofisica.org.ar/reuniones-cientificas/reunionsab-previas/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Nacional
dc.publisher.none.fl_str_mv Sociedad Argentina de Biofísica
publisher.none.fl_str_mv Sociedad Argentina de Biofísica
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269906773475328
score 13.13397